Movement Breaks for Type 2 Diabetes
Trial Summary
Do I have to stop taking my current medications for the trial?
No, you can continue taking your current medications as long as the dosage has been stable for at least 6 months and you can maintain the same doses during the study.
What data supports the effectiveness of the treatment Movement breaks for Type 2 Diabetes?
Research shows that regular physical activity, including low-intensity exercises and movement breaks, can help manage type 2 diabetes by improving blood sugar control and reducing related health issues. Studies have demonstrated that incorporating physical activity into daily routines can lead to better long-term health outcomes for individuals with type 2 diabetes.12345
Is it safe for people with type 2 diabetes to take movement breaks?
Movement breaks, or low-intensity exercise, are generally safe for people with type 2 diabetes if certain precautions are taken. While there is a low risk of mild to severe issues like muscle injuries or low blood sugar, these can be managed with proper guidance and personalized exercise plans.678910
How do movement breaks differ from other treatments for type 2 diabetes?
Movement breaks involve short, low-intensity physical activities throughout the day, which can help lower fasting blood sugar levels and reduce daily blood sugar fluctuations. This approach is different from traditional exercise programs that often require longer, more intense sessions, making it a more accessible option for people who find it challenging to commit to regular exercise routines.911121314
What is the purpose of this trial?
To conduct a randomized crossover trial to determine the acute impact of low-intensity movement breaks on glycemic control in physically inactive individuals living with type 2 diabetes using continuous glucose monitoring.
Research Team
Jonathan Little, PhD
Principal Investigator
University of British Columbia
Eligibility Criteria
This trial is for inactive adults aged 30-75 with type 2 diabetes, a BMI of 18.5-40, stable medication doses for the past 6 months, and an HbA1c of ≤8.5%. Participants must not be doing more than 150 minutes of moderate exercise weekly and should have access to digital devices for intervention tracking.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Exercise Condition (EX)
Participants perform four low-intensity movement breaks per day on two consecutive days while wearing a continuous glucose monitor
Control Condition (CON)
Participants refrain from any structured exercise during two consecutive days while wearing a continuous glucose monitor
Follow-up
Participants are monitored for safety and effectiveness after the trial conditions
Treatment Details
Interventions
- Movement breaks
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
McMaster University
Collaborator